<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1276"/><api:result><api:object category="publication" id="1276" last-affected-when="2024-04-18T08:33:24.33+01:00" last-modified-when="2024-04-18T08:33:24.33+01:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1276" created-when="2010-05-17T13:47:35.463+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2000-01-01</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="1518220" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1097/00008390-200008000-00003" last-modified-when="2024-01-13T13:58:18.563+00:00"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Hedley</api:last-name><api:initials>SJ</api:initials><api:first-names>SJ</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Murray</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1450" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1450"/></api:links><api:last-name>Sisley</api:last-name><api:initials>K</api:initials><api:first-names>K</api:first-names><api:separate-first-names><api:first-name>K</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ghanem</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Morandini</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Gawkrodger</api:last-name><api:initials>DJ</api:initials><api:first-names>DJ</api:first-names><api:separate-first-names><api:first-name>D</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Mac Neil</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1097/00008390-200008000-00003</api:text><api:links><api:link type="doi" href="http://doi.org/10.1097/00008390-200008000-00003"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1097/00008390-200008000-00003"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0960-8931</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974245"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Melanoma Research</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>323</api:begin-page><api:end-page>330</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Ovid Technologies (Wolters Kluwer Health)</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1097/00008390-200008000-00003</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>5</api:day><api:month>1</api:month><api:year>2024</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>α-Melanocyte stimulating hormone can reduce T-cell interaction with melanoma cells in vitro</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>10</api:text></api:field></api:native></api:record><api:record format="native" id="95616" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0033822075" last-modified-when="2024-03-27T02:25:23.07+00:00"><api:citation-count>15</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>This study was undertaken to investigate whether α-melanocyte stimulating hormone (αMSH) influences the interaction of melanoma cells with T-lymphocytes in the light of previous work from our laboratories showing that αMSH can reduce tumour necrosis factor-α (TNFα) stimulated ICAM-1 upregulation in both normal and transformed melanocytes. Two cutaneous melanoma cell lines - A375-SM and HBL - were examined initially. A375-SM cells gave only a two-fold increase in T-cell proliferation, which was not much improved by the pretreatment of the melanoma cells with cytokines. HBL cells induced a three-fold increase in T-cell proliferation, which was slightly enhanced by the addition of cytokines. Neither cell line expressed B71. HBL cells expressed a low level of B72, whereas A375-SM cells had little, if any, B72 expression. Addition of αMSH reduced the interaction between these cutaneous melanoma cells and T-lymphocytes in some, but not all, conditions. An ocular melanoma cell line transfected with B7 showed a modest interaction with T-cells (in two out of three donors) and this response was reduced by the addition of αMSH. Pretreatment of the transfected line with cytokines markedly enhanced stimulation of T-cell proliferation by these tumour cells, and αMSH reduced the interaction between melanoma cells and T-cells for two out of three donors. In summary, under experimental conditions where melanoma cell stimulation of T-cells occurred (generally pretreatment of the cells with interferon-γ gave the most convincing response), αMSH reduced this response in the majority of experiments, providing preliminary evidence to confirm the hypothesis that MSH may assist melanoma cells to evade interaction with immune cells. (C) 2000 Lippincott Williams and Wilkins.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Hedley</api:last-name><api:initials>SJ</api:initials><api:first-names>SJ</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Northern General Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6701529971</api:identifier></api:identifiers></api:person><api:person><api:last-name>Murray</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Sheffield Medical School</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7401933281</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="1450" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1450"/></api:links><api:last-name>Sisley</api:last-name><api:initials>K</api:initials><api:first-names>K</api:first-names><api:separate-first-names><api:first-name>K</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Sheffield Medical School</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6603976159</api:identifier></api:identifiers></api:person><api:person><api:last-name>Ghanem</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="BE"><api:line type="organisation">Université Libre de Bruxelles</api:line><api:line type="city">Brussels</api:line><api:line type="country">Belgium</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005487533</api:identifier></api:identifiers></api:person><api:person><api:last-name>Morandini</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="BE"><api:line type="organisation">Université Libre de Bruxelles</api:line><api:line type="city">Brussels</api:line><api:line type="country">Belgium</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">57225241967</api:identifier></api:identifiers></api:person><api:person><api:last-name>Gawkrodger</api:last-name><api:initials>DJ</api:initials><api:first-names>DJ</api:first-names><api:separate-first-names><api:first-name>D</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Royal Hallamshire Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005074066</api:identifier></api:identifiers></api:person><api:person><api:last-name>Mac Neil</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Northern General Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7004187150</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1097/00008390-200008000-00003</api:text><api:links><api:link type="doi" href="http://doi.org/10.1097/00008390-200008000-00003"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1097/00008390-200008000-00003"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10985666</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0960-8931</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974245"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Melanoma Research</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>323</api:begin-page><api:end-page>330</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>1</api:day><api:month>1</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>α-Melanocyte stimulating hormone can reduce T-cell interaction with melanoma cells in vitro</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>10</api:text></api:field></api:native></api:record><api:record format="native" id="1276" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10985666" last-modified-when="2020-04-29T06:09:10.83+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>This study was undertaken to investigate whether alpha-melanocyte stimulating hormone (alphaMSH) influences the interaction of melanoma cells with T-lymphocytes in the light of previous work from our laboratories showing that alphaMSH can reduce tumour necrosis factor-alpha (TNFalpha) stimulated ICAM-1 upregulation in both normal and transformed melanocytes. Two cutaneous melanoma cell lines--A375-SM and HBL--were examined initially. A375-SM cells gave only a two-fold increase in T-cell proliferation, which was not much improved by the pretreatment of the melanoma cells with cytokines. HBL cells induced a three-fold increase in T-cell proliferation, which was slightly enhanced by the addition of cytokines. Neither cell line expressed B7(1), HBL cells expressed a low level of B7(2), whereas A375-SM cells had little, if any, B7(2) expression. Addition of alphaMSH reduced the interaction between these cutaneous melanoma cells and T-lymphocytes in some, but not all, conditions. An ocular melanoma cell line transfected with B7 showed a modest interaction with T-cells (in two out of three donors) and this response was reduced by the addition of alphaMSH. Pretreatment of the transfected line with cytokines markedly enhanced stimulation of T-cell proliferation by these tumour cells, and alphaMSH reduced the interaction between melanoma cells and T-cells for two out of three donors. In summary, under experimental conditions where melanoma cell stimulation of T-cells occurred (generally pretreatment of the cells with interferon-gamma gave the most convincing response), alphaMSH reduced this response in the majority of experiments, providing preliminary evidence to confirm the hypothesis that MSH may assist melanoma cells to evade interaction with immune cells.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Hedley</api:last-name><api:initials>SJ</api:initials><api:first-names>SJ</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Division of Clinical Sciences, Northern General Hospital, Sheffield, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Murray</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1450" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1450"/></api:links><api:last-name>Sisley</api:last-name><api:initials>K</api:initials><api:first-names>K</api:first-names><api:separate-first-names><api:first-name>K</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ghanem</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Morandini</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Gawkrodger</api:last-name><api:initials>DJ</api:initials><api:first-names>DJ</api:first-names><api:separate-first-names><api:first-name>D</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Mac Neil</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10985666</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1097/00008390-200008000-00003</api:text><api:links><api:link type="doi" href="http://doi.org/10.1097/00008390-200008000-00003"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1097/00008390-200008000-00003"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0960-8931</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974245"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Melanoma Res</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Antibodies, Monoclonal</api:keyword><api:keyword scheme="mesh">Antigens, CD</api:keyword><api:keyword scheme="mesh">B7-1 Antigen</api:keyword><api:keyword scheme="mesh">B7-2 Antigen</api:keyword><api:keyword scheme="mesh">CD58 Antigens</api:keyword><api:keyword scheme="mesh">Cell Communication</api:keyword><api:keyword scheme="mesh">Coculture Techniques</api:keyword><api:keyword scheme="mesh">Eye Neoplasms</api:keyword><api:keyword scheme="mesh">Histocompatibility Antigens Class I</api:keyword><api:keyword scheme="mesh">Histocompatibility Antigens Class II</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Intercellular Adhesion Molecule-1</api:keyword><api:keyword scheme="mesh">Lymphocyte Activation</api:keyword><api:keyword scheme="mesh">Melanoma</api:keyword><api:keyword scheme="mesh">Membrane Glycoproteins</api:keyword><api:keyword scheme="mesh">Skin Neoplasms</api:keyword><api:keyword scheme="mesh">T-Lymphocytes</api:keyword><api:keyword scheme="mesh">Transfection</api:keyword><api:keyword scheme="mesh">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh">alpha-MSH</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>323</api:begin-page><api:end-page>330</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>4</api:day><api:month>1</api:month><api:year>2001</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Alpha-melanocyte stimulating hormone can reduce T-cell interaction with melanoma cells in vitro.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>10</api:text></api:field></api:native></api:record><api:record format="native" id="882356" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10985666" last-modified-when="2024-03-26T19:43:00.133+00:00"><api:citation-count>12</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>This study was undertaken to investigate whether alpha-melanocyte stimulating hormone (alphaMSH) influences the interaction of melanoma cells with T-lymphocytes in the light of previous work from our laboratories showing that alphaMSH can reduce tumour necrosis factor-alpha (TNFalpha) stimulated ICAM-1 upregulation in both normal and transformed melanocytes. Two cutaneous melanoma cell lines--A375-SM and HBL--were examined initially. A375-SM cells gave only a two-fold increase in T-cell proliferation, which was not much improved by the pretreatment of the melanoma cells with cytokines. HBL cells induced a three-fold increase in T-cell proliferation, which was slightly enhanced by the addition of cytokines. Neither cell line expressed B7(1), HBL cells expressed a low level of B7(2), whereas A375-SM cells had little, if any, B7(2) expression. Addition of alphaMSH reduced the interaction between these cutaneous melanoma cells and T-lymphocytes in some, but not all, conditions. An ocular melanoma cell line transfected with B7 showed a modest interaction with T-cells (in two out of three donors) and this response was reduced by the addition of alphaMSH. Pretreatment of the transfected line with cytokines markedly enhanced stimulation of T-cell proliferation by these tumour cells, and alphaMSH reduced the interaction between melanoma cells and T-cells for two out of three donors. In summary, under experimental conditions where melanoma cell stimulation of T-cells occurred (generally pretreatment of the cells with interferon-gamma gave the most convincing response), alphaMSH reduced this response in the majority of experiments, providing preliminary evidence to confirm the hypothesis that MSH may assist melanoma cells to evade interaction with immune cells.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Division of Clinical Sciences, Northern General Hospital, Sheffield, UK.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Hedley</api:last-name><api:initials>SJ</api:initials><api:first-names>SJ</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Murray</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1450" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1450"/></api:links><api:last-name>Sisley</api:last-name><api:initials>K</api:initials><api:first-names>K</api:first-names><api:separate-first-names><api:first-name>K</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0002-5565-2618</api:identifier></api:identifiers></api:person><api:person><api:last-name>Ghanem</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Morandini</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Gawkrodger</api:last-name><api:initials>DJ</api:initials><api:first-names>DJ</api:first-names><api:separate-first-names><api:first-name>D</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Mac Neil</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1097/00008390-200008000-00003</api:text><api:links><api:link type="doi" href="http://doi.org/10.1097/00008390-200008000-00003"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1097/00008390-200008000-00003"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1473-5636</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974245"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10985666</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0960-8931</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974245"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Melanoma research</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">T-Lymphocytes</api:keyword><api:keyword scheme="mesh">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Melanoma</api:keyword><api:keyword scheme="mesh">Eye Neoplasms</api:keyword><api:keyword scheme="mesh">Skin Neoplasms</api:keyword><api:keyword scheme="mesh">alpha-MSH</api:keyword><api:keyword scheme="mesh">Membrane Glycoproteins</api:keyword><api:keyword scheme="mesh">Intercellular Adhesion Molecule-1</api:keyword><api:keyword scheme="mesh">Antigens, CD</api:keyword><api:keyword scheme="mesh">Antibodies, Monoclonal</api:keyword><api:keyword scheme="mesh">Histocompatibility Antigens Class I</api:keyword><api:keyword scheme="mesh">Histocompatibility Antigens Class II</api:keyword><api:keyword scheme="mesh">Coculture Techniques</api:keyword><api:keyword scheme="mesh">Transfection</api:keyword><api:keyword scheme="mesh">Lymphocyte Activation</api:keyword><api:keyword scheme="mesh">Cell Communication</api:keyword><api:keyword scheme="mesh">B7-1 Antigen</api:keyword><api:keyword scheme="mesh">CD58 Antigens</api:keyword><api:keyword scheme="mesh">B7-2 Antigen</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>323</api:begin-page><api:end-page>330</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>14</api:day><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Alpha-melanocyte stimulating hormone can reduce T-cell interaction with melanoma cells in vitro.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>10</api:text></api:field></api:native></api:record><api:record format="native" id="2709755" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1034648105" last-modified-when="2024-03-16T18:08:59.77+00:00"><api:citation-count>15</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Hedley</api:last-name><api:initials>SJ</api:initials><api:first-names>SJ</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Northern General Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01273662201.75</api:identifier></api:identifiers></api:person><api:person><api:last-name>Murray</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Northern General Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses></api:person><api:person><api:links><api:link type="elements/user" id="1450" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1450"/></api:links><api:last-name>Sisley</api:last-name><api:initials>K</api:initials><api:first-names>K</api:first-names><api:separate-first-names><api:first-name>K</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Northern General Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01033471671.77</api:identifier></api:identifiers></api:person><api:person><api:last-name>Ghanem</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Northern General Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0576616237.53</api:identifier></api:identifiers></api:person><api:person><api:last-name>Morandini</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Northern General Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0743421130.88</api:identifier></api:identifiers></api:person><api:person><api:last-name>Gawkrodger</api:last-name><api:initials>DJ</api:initials><api:first-names>DJ</api:first-names><api:separate-first-names><api:first-name>D</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Northern General Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0672326745.32</api:identifier></api:identifiers></api:person><api:person><api:last-name>Neil</api:last-name><api:initials>SM</api:initials><api:first-names>S Mac</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>Mac</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">Northern General Hospital</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.015044373253.21</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1097/00008390-200008000-00003</api:text><api:links><api:link type="doi" href="http://doi.org/10.1097/00008390-200008000-00003"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1097/00008390-200008000-00003"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10985666</api:identifier></api:identifiers></api:field><api:field name="field-citation-ratio" type="decimal" display-name="Field citation ratio"><api:decimal>1.49</api:decimal></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0960-8931</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974245"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Melanoma Research</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3211 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="for-2020">3204 Immunology</api:keyword><api:keyword scheme="rcdc">Cancer</api:keyword><api:keyword scheme="hrcs-rac">2 Aetiology</api:keyword><api:keyword scheme="hrcs-rac">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="hrcs-hc">Cancer</api:keyword><api:keyword scheme="mesh">Antibodies, Monoclonal</api:keyword><api:keyword scheme="mesh">Antigens, CD</api:keyword><api:keyword scheme="mesh">B7-1 Antigen</api:keyword><api:keyword scheme="mesh">B7-2 Antigen</api:keyword><api:keyword scheme="mesh">CD58 Antigens</api:keyword><api:keyword scheme="mesh">Cell Communication</api:keyword><api:keyword scheme="mesh">Coculture Techniques</api:keyword><api:keyword scheme="mesh">Eye Neoplasms</api:keyword><api:keyword scheme="mesh">Histocompatibility Antigens Class I</api:keyword><api:keyword scheme="mesh">Histocompatibility Antigens Class II</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Intercellular Adhesion Molecule-1</api:keyword><api:keyword scheme="mesh">Lymphocyte Activation</api:keyword><api:keyword scheme="mesh">Melanoma</api:keyword><api:keyword scheme="mesh">Membrane Glycoproteins</api:keyword><api:keyword scheme="mesh">Skin Neoplasms</api:keyword><api:keyword scheme="mesh">T-Lymphocytes</api:keyword><api:keyword scheme="mesh">Transfection</api:keyword><api:keyword scheme="mesh">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh">alpha-MSH</api:keyword></api:keywords></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Closed Access</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>323</api:begin-page><api:end-page>330</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Wolters Kluwer</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>0.3</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>α-Melanocyte stimulating hormone can reduce T-cell interaction with melanoma cells in vitro</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>10</api:text></api:field></api:native></api:record><api:record format="native" id="242152" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000088963400003" last-modified-when="2024-04-10T20:32:54.693+01:00"><api:citation-count>13</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Hedley</api:last-name><api:initials>SJ</api:initials><api:first-names>SJ</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Murray</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1450" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1450"/></api:links><api:last-name>Sisley</api:last-name><api:initials>K</api:initials><api:first-names>K</api:first-names><api:separate-first-names><api:first-name>K</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="researcherid">B-7296-2019</api:identifier></api:identifiers></api:person><api:person><api:last-name>Ghanem</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Morandini</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Gawkrodger</api:last-name><api:initials>DJ</api:initials><api:first-names>DJ</api:first-names><api:separate-first-names><api:first-name>D</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="researcherid">AFO-6373-2022</api:identifier></api:identifiers></api:person><api:person><api:last-name>Mac Neil</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000088963400003&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1097/00008390-200008000-00003</api:text><api:links><api:link type="doi" href="http://doi.org/10.1097/00008390-200008000-00003"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1097/00008390-200008000-00003"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1473-5636</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974245"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">348BD</api:identifier><api:identifier scheme="pubmed">10985666</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0960-8931</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974245"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>MELANOMA RESEARCH</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>alpha MSH</api:keyword><api:keyword>immunosuppression</api:keyword><api:keyword>melanoma</api:keyword><api:keyword>T-lymphocytes</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>323</api:begin-page><api:end-page>330</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>α-Melanocyte stimulating hormone can reduce T-cell interaction with melanoma cells &lt;i&gt;in vitro&lt;/i&gt;</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>10</api:text></api:field></api:native></api:record><api:record format="native" id="25365" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000088963400003" last-modified-when="2014-12-16T07:32:30.523+00:00"><api:citation-count>9</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Hedley</api:last-name><api:initials>SJ</api:initials><api:first-names>SJ</api:first-names><api:separate-first-names><api:first-name>S</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Murray</api:last-name><api:initials>A</api:initials><api:first-names>A</api:first-names><api:separate-first-names><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="1450" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1450"/></api:links><api:last-name>Sisley</api:last-name><api:initials>K</api:initials><api:first-names>K</api:first-names><api:separate-first-names><api:first-name>K</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ghanem</api:last-name><api:initials>G</api:initials><api:first-names>G</api:first-names><api:separate-first-names><api:first-name>G</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Morandini</api:last-name><api:initials>R</api:initials><api:first-names>R</api:first-names><api:separate-first-names><api:first-name>R</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Gawkrodger</api:last-name><api:initials>DJ</api:initials><api:first-names>DJ</api:first-names><api:separate-first-names><api:first-name>D</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Mac Neil</api:last-name><api:initials>S</api:initials><api:first-names>S</api:first-names><api:separate-first-names><api:first-name>S</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0960-8931</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974245"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>4</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>MELANOMA RES</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>alpha MSH</api:keyword><api:keyword>immunosuppression</api:keyword><api:keyword>melanoma</api:keyword><api:keyword>T-lymphocytes</api:keyword><api:keyword>OPIOMELANOCORTIN-DERIVED PEPTIDES</api:keyword><api:keyword>CULTURED HUMAN MELANOCYTES</api:keyword><api:keyword>MALIGNANT-MELANOMA</api:keyword><api:keyword>HUMAN SKIN</api:keyword><api:keyword>HUMAN KERATINOCYTES</api:keyword><api:keyword>ANTITUMOR IMMUNITY</api:keyword><api:keyword>IN-VITRO</api:keyword><api:keyword>EXPRESSION</api:keyword><api:keyword>PROOPIOMELANOCORTIN</api:keyword><api:keyword>MSH</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>323</api:begin-page><api:end-page>330</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>alpha-Melanocyte stimulating hormone can reduce T-cell interaction with melanoma cells in vitro</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>10</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Antibodies, Monoclonal</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Antigens, CD</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">B7-1 Antigen</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">B7-2 Antigen</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">CD58 Antigens</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Cell Communication</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Coculture Techniques</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Eye Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Histocompatibility Antigens Class I</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Histocompatibility Antigens Class II</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Intercellular Adhesion Molecule-1</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Lymphocyte Activation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Melanoma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Membrane Glycoproteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Skin Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">T-Lymphocytes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Transfection</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">alpha-MSH</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">T-Lymphocytes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Melanoma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Eye Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Skin Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">alpha-MSH</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Membrane Glycoproteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Intercellular Adhesion Molecule-1</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Antigens, CD</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Antibodies, Monoclonal</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Histocompatibility Antigens Class I</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Histocompatibility Antigens Class II</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Coculture Techniques</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Transfection</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Lymphocyte Activation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Cell Communication</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">B7-1 Antigen</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">CD58 Antigens</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">B7-2 Antigen</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3211 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3204 Immunology</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Cancer</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2 Aetiology</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">2.1 Biological and endogenous factors</api:keyword><api:keyword scheme="hrcs-hc" origin="record-data" source="dimensions">Cancer</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Antibodies, Monoclonal</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Antigens, CD</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">B7-1 Antigen</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">B7-2 Antigen</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">CD58 Antigens</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Cell Communication</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Coculture Techniques</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Eye Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Histocompatibility Antigens Class I</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Histocompatibility Antigens Class II</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Intercellular Adhesion Molecule-1</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Lymphocyte Activation</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Melanoma</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Membrane Glycoproteins</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Skin Neoplasms</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">T-Lymphocytes</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Transfection</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Tumor Cells, Cultured</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">alpha-MSH</api:keyword><api:keyword origin="record-data" source="wos-lite">alpha MSH</api:keyword><api:keyword origin="record-data" source="wos-lite">immunosuppression</api:keyword><api:keyword origin="record-data" source="wos-lite">melanoma</api:keyword><api:keyword origin="record-data" source="wos-lite">T-lymphocytes</api:keyword><api:keyword origin="record-data" source="wos">alpha MSH</api:keyword><api:keyword origin="record-data" source="wos">immunosuppression</api:keyword><api:keyword origin="record-data" source="wos">melanoma</api:keyword><api:keyword origin="record-data" source="wos">T-lymphocytes</api:keyword><api:keyword origin="record-data" source="wos">OPIOMELANOCORTIN-DERIVED PEPTIDES</api:keyword><api:keyword origin="record-data" source="wos">CULTURED HUMAN MELANOCYTES</api:keyword><api:keyword origin="record-data" source="wos">MALIGNANT-MELANOMA</api:keyword><api:keyword origin="record-data" source="wos">HUMAN SKIN</api:keyword><api:keyword origin="record-data" source="wos">HUMAN KERATINOCYTES</api:keyword><api:keyword origin="record-data" source="wos">ANTITUMOR IMMUNITY</api:keyword><api:keyword origin="record-data" source="wos">IN-VITRO</api:keyword><api:keyword origin="record-data" source="wos">EXPRESSION</api:keyword><api:keyword origin="record-data" source="wos">PROOPIOMELANOCORTIN</api:keyword><api:keyword origin="record-data" source="wos">MSH</api:keyword><api:keyword scheme="for" origin="issn-inferred">1103 Clinical Sciences</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Oncology &amp; Carcinogenesis</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3202 Clinical sciences</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3211 Oncology and carcinogenesis</api:keyword></api:keywords></api:all-labels><api:journal issn="0960-8931" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/974245" title="Melanoma Research"><api:records><api:record source-name="summary"><api:title>Melanoma Research</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1276/relationships"/></api:object></api:result></api:response>